Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CardioFocus
A randomized, controlled trial designed to demonstrate the safety and effectiveness of the experimental device to deliver pulmonary vein isolation as a treatment for symptomatic atrial fibrillation.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 to 75 years.
paroxysmal atrial fibrillation
failure of at least one AAD
others
You may not be if
overall good health as established by multiple criteria
Clareo Health | HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)
